ranimustine has been researched along with Cancer of Stomach in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taguchi, T | 1 |
| Ikeda, Y; Kobayashi, M; Kobayashi, T; Ohno, R; Ohta, K; Shirakawa, S; Tanaka, I; Yamada, H; Yamada, K; Yamagata, K | 1 |
| Hattori, T; Hosoma, S; Iwamori, S; Kobayashi, S; Nagata, N; Niimoto, M; Nishimawari, K; Ogawa, Y; Yamagata, S; Yoshinaka, K | 1 |
3 other study(ies) available for ranimustine and Cancer of Stomach
| Article | Year |
|---|---|
[A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Rectal Neoplasms; Stomach Neoplasms | 1984 |
[Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Drug Evaluation; Female; Hematologic Diseases; Humans; Leukemia; Leukemia, Myeloid; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Polycythemia Vera; Stomach Neoplasms; Thrombocytopenia | 1985 |
[Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
Topics: Antineoplastic Agents; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Gastrointestinal Neoplasms; Humans; Leukocyte Count; Liver Neoplasms; Nitrosourea Compounds; Pancreatic Neoplasms; Stomach Neoplasms | 1985 |